ResearcherJining Medical UniversityNo recent work listed
Qiang Ren
Matched on ORCID iD 0000-0002-4728-8676; OpenAlex author ID A5072653042. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2021: 2 papers · 2022: 1 paper · 2023: 2 papers
Papers 5
- The Novel SLRP Family Member Lumican Suppresses Pancreatic Cancer Cell Growth. Co-author DOI 10.1097/mpa.0000000000002211↗
- Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, Invasion, and Angiogenesis in Pancreatic C… Co-author DOI 10.3390/molecules28207205↗
- Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. Co-author DOI 10.1016/j.tice.2022.101867↗
- Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. Co-author DOI 10.1016/j.jpba.2021.114339↗
- Study on the expression profile and role of decorin in the progression of pancreatic cancer. Co-author DOI 10.18632/aging.203060↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuntao Zhang · 5 shared papers, 2021–2023 · strength 0.76
- Paper The Novel SLRP Family Member Lumican Suppresses Pancreatic Cancer Cell Growth. DOI 10.1097/mpa.0000000000002211↗
- Paper Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, In… DOI 10.3390/molecules28207205↗
- Paper Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. DOI 10.1016/j.tice.2022.101867↗
- Huijie Gao · 4 shared papers, 2021–2023 · strength 0.63
- Paper The Novel SLRP Family Member Lumican Suppresses Pancreatic Cancer Cell Growth. DOI 10.1097/mpa.0000000000002211↗
- Paper Elaiophylin Elicits Robust Anti-Tumor Responses via Apoptosis Induction and Attenuation of Proliferation, Migration, In… DOI 10.3390/molecules28207205↗
- Paper Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. DOI 10.1016/j.tice.2022.101867↗
- Litao Zhang · 4 shared papers, 2021–2023 · strength 0.58
- Paper The Novel SLRP Family Member Lumican Suppresses Pancreatic Cancer Cell Growth. DOI 10.1097/mpa.0000000000002211↗
- Paper Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. DOI 10.1016/j.tice.2022.101867↗
- Paper Study on the expression profile and role of decorin in the progression of pancreatic cancer. DOI 10.18632/aging.203060↗
- Wei Qin · 3 shared papers, 2021–2022 · strength 0.38
- Paper Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. DOI 10.1016/j.tice.2022.101867↗
- Paper Study on the expression profile and role of decorin in the progression of pancreatic cancer. DOI 10.18632/aging.203060↗
- Paper Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. DOI 10.1016/j.jpba.2021.114339↗
- Lingxin Meng · 3 shared papers, 2021–2022 · strength 0.38
- Paper Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. DOI 10.1016/j.tice.2022.101867↗
- Paper Study on the expression profile and role of decorin in the progression of pancreatic cancer. DOI 10.18632/aging.203060↗
- Paper Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. DOI 10.1016/j.jpba.2021.114339↗
- Sen Qiao · 2 shared papers, 2021–2022 · strength 0.25
- Anguo Wu · 1 shared paper, 2023 · strength 0.18
- Lufen Huang · 1 shared paper, 2023 · strength 0.18
- Jing Zhang · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.